Related Experiment Videos

Analgesic efficacy of tramadol 2 mg kg(-1) for paediatric day-case adenoidectomy

H Viitanen1, P Annila

  • 1Department of Surgery and Anaesthesia, Central Hospital of Seinäjoki, Finland.

Insights

Tramadol effectively reduced the need for rescue analgesia in children aged 1-3 years after adenoidectomy. Significantly fewer children receiving tramadol required additional pain medication post-surgery.

Area of Science:

  • Pediatric Anesthesiology
  • Pain Management
  • Pharmacology

Background:

  • Post-operative pain management in children undergoing adenoidectomy is crucial for recovery.
  • Optimizing analgesia while minimizing adverse effects is a key clinical challenge.

Purpose of the Study:

  • To evaluate the analgesic efficacy of intravenous tramadol in young children (1-3 years) after day-case adenoidectomy.
  • To compare the need for rescue analgesia and recovery outcomes between tramadol and placebo groups.

Main Methods:

  • A randomized controlled trial involving 80 children aged 1-3 years undergoing adenoidectomy.
  • Children received either intravenous tramadol (2 mg/kg) or placebo post-induction of anesthesia.
  • Pain and recovery assessments were conducted by a blinded observer, with rescue medication administered as needed.

Main Results:

  • Children in the tramadol group required significantly fewer doses of rescue pethidine (P = 0.014).
  • Forty-five percent of children receiving tramadol did not require any post-operative analgesia, compared to 15% in the placebo group (P = 0.003).
  • Recovery times and adverse event incidence were similar between groups.

Conclusions:

  • Intravenous tramadol (2 mg/kg) provides effective post-operative analgesia in children aged 1-3 years after adenoidectomy.
  • Tramadol administration significantly reduces the need for supplementary analgesics without increasing adverse effects or delaying recovery.

Related Concept Videos